Andrew Huberman has thoughts on testosterone replacement therapy (TRT) and peptides. The 51-year-old neuroscientist and podcaster started microdosing TRT at 45, but has never taken a GLP-1. “I know you can get great results from them, but I’m not experimenting with peptides personally right now,” he says. “I may in the future, but I’m just going to stick [with TRT].” Watch the full #gymandfridge at the link in bio. #trt #testosterone #glp1 #peptides